Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A6 | Q3KNW5 | 2/20 | 0.72 |
| ▸ | SLC10A2 | Q12908 | 1/20 | 0.72 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.62 |
| ▸ | MEN1 | O00255 | 8/20 | 0.62 |
| ▸ | LMNA | P02545 | 7/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.62 |
| ▸ | MAPT | P10636 | 6/20 | 0.62 |
| ▸ | HTT | P42858 | 7/20 | 0.61 |
| ▸ | RECQL | P46063 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | PRSS12 | P56730 | 1/20 | 0.48 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.48 |
| ▸ | CCR2 | P41597 | 1/20 | 0.45 |
| ▸ | SLC20A2 | Q08357 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120571 | 0.96 | SMN1; SMN2 (0.65) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL7213170 | 0.91 | MEN1 (0.76) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL7208737 | 0.91 | MEN1 (0.67) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL6756862 | 0.84 | SLC10A6 (1.00) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL492639 | 0.83 | SLC10A6 (0.56) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL7126120 | 0.83 | SLC10A6 (0.98) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL7213034 | 0.82 | MEN1 (0.57) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL492342 | 0.81 | MEN1 (0.59) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL492766 | 0.81 | SLC10A2 (0.52) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 | |
| SCHEMBL492769 | 0.81 | SLC10A2 (0.52) | SLC10A6SLC10A2SLC10A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187531-A4 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-28 | — | — | EP | claimed |
| US-6458845-B1 | METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A | SMITHKLINE BEECHAM CORPORATION | 2002-10-01 | — | — | US | claimed |
| EP-1187531-A1 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SmithKline Beecham Corporation (US) | 2002-03-20 | — | — | EP | claimed |
| WO-2001098264-A1 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-12-27 | — | — | WO | claimed |
| WO-2000078145-A1 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-12-28 | — | — | WO | claimed |